Document Detail


Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an automated cell-processing system.
MedLine Citation:
PMID:  19845078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
RBC components with rare phenotypes are sometimes required for patients with sickle cell disease, and these rare components can often be found among donors with sickle cell trait. Cryopreserving RBC components from sickle cell trait donors requires a modified deglycerolization method to preserve the integrity of the RBCs. This study evaluated the feasibility of using an automated cell-processing system to cryopreserve and deglycerolize sickle cell trait donor RBC components. CP2D/AS-3 RBC components were collected from three donors with sickle cell trait. Each component was processed with an automated cell-processing system (ACP 215, Haemonetics Corp., Braintree, MA) and cryopreserved within 6 days of collection. The components were stored at -65 degrees C or less for at least 2 days and were deglycerolized using the automated cell-processing system's standard procedure. Before cryopreservation and after deglycerolization, several variables were measured. Deglycerolization resulted in recovery of 43.0, 76.5, and 67.5 percent of RBCs from the three sickle-cell-trait donor components compared with 80 percent or greater for all six control components. A small, dark red, jelly-like mass was noted in the bowl of the disposable set after deglycerolization of each of the three RBC sickle cell trait components. The osmolalities of all three sickle cell trait components were less than 400 mOsm/kg, but only one of the three was acceptable for a 14-day outdate. Freezing and deglycerolization of sickle cell trait donor RBC components with the automated cell-processing system resulted in recovery of some RBCs, but a decrease in RBC recovery was problematic. Modifications of the procedure are needed for processing sickle cell trait donor RBC components.
Authors:
R J Ackley; A H Lee-Stroka; B J Bryant; D F Stroncek; K M Byrne
Related Documents :
18710708 - Cryopreservation has no effect on meiotic recombination and synapsis in testicular tiss...
20645048 - Cryopreservation of human hepatocytes for clinical use.
12898278 - The effects of different intraocular irrigating solutions on the apoptosis of cultured ...
19179738 - Sickle cell anemia in garasia tribals of rajasthan.
9768468 - Mapping cell wall polysaccharides of living microbial cells using atomic force microscopy.
19827308 - Cytotoxic piperazine-2,5-dione derivatives from marine fungus gliocladium sp.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Immunohematology / American Red Cross     Volume:  24     ISSN:  0894-203X     ISO Abbreviation:  Immunohematology     Publication Date:  2008  
Date Detail:
Created Date:  2009-10-22     Completed Date:  2009-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8806387     Medline TA:  Immunohematology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  107-12     Citation Subset:  IM    
Affiliation:
George Washington University Hospital, Transfusion Medicine, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Donors*
Cryopreservation*
Cryoprotective Agents
Cytapheresis / instrumentation*,  methods*
Erythrocytes, Abnormal / cytology*
Glycerol
Humans
Sickle Cell Trait*
Chemical
Reg. No./Substance:
0/Cryoprotective Agents; 56-81-5/Glycerol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transfusion service disaster planning.
Next Document:  Overt immediate hemolytic transfusion reaction attributable to anti-Wr(a).